ArticleHeliyon2024

ANKRD2 expression combined with TNFRSF19 expression for evaluating the prognosis of oral squamous cell carcinoma patients.

Shucong Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.